Health Universe lands $6M seed to build “auditable AI” for healthcare
Health Universe, a San Francisco-based healthtech startup founded by Dan Caron, has raised a $6 million seed round led by Kleiner Perkins, bringing total funding to $9.5 million. The company is positioning itself around a core promise that has become increasingly important as regulators scrutinize clinical AI: tools that are not just accurate, but auditable.
Why auditability matters in regulated medicine
Clinical trial enrollment and setup remain slow, with some protocols taking months to reach first patient. At the same time, clinicians face heavy administrative workloads. While investment in medical AI has surged, many systems still behave like “black boxes,” producing outputs without a clear, reviewable rationale—an issue when accountability and patient safety are on the line.
Health Universe says it addresses this gap by generating source-linked outputs, where summaries and recommendations point back to underlying clinical records or data. It also offers Observer, a monitoring dashboard designed to track errors, query costs, and flag potentially risky outputs.
Regulatory positioning: ONC B.11, not FDA clearance
The company states it holds ONC B.11 certification under the 21st Century Cures Act for decision support interventions. B.11 emphasizes transparent logic that clinicians can review and allows users to opt out of recommendations. The certification is distinct from HIPAA attestations and does not equate to FDA clearance for diagnostic decision-making.
Pilot results and competitive landscape
In a pilot with the Duke Clinical Research Institute, the startup claims it reduced clinical trial setup time by 30–40x, saving 93% of total time. The company’s platform includes Navigator (a secure workspace for deploying agents via TEFCA or FHIR), Explorer (for population cohort building), and custom agents for oncology chart review and protocol drafting. Competitors cited include Nabla, Tempus, and Insilico Medicine.
What the funding will support next
Kleiner Perkins’ seed leadership signals growing investor focus on compliance infrastructure as the regulatory bar rises for healthcare AI. Health Universe plans to expand deployments across academic medical centers and develop an Agent-to-Agent (A2A) Marketplace for controlled document sharing between organizations—an ambitious vision that remains to be proven at scale.
Related
